Top Markets
Coin of the day
NovaBridge Biosciences NovaBridge Biosciences

NovaBridge Biosciences

NBP
Clasificación en acciones #18279
NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering... NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several significant drug candidates: givastomig, a bispecific antibody currently in Phase 1b clinical trials for gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, another bispecific antibody, which is undergoing Phase 1 clinical evaluation for solid tumors. The company maintains a strategic licensing agreement with Ferring International Center SA, encompassing the research, development, manufacturing, import, use, and commercialization rights for FE301, an interleukin-6 inhibitor. Additionally, NovaBridge Biosciences has established collaborations with Bristol Myers Squibb for givastomig's advancement, ABL Bio, Inc. for both givastomig and ragistomig, and TJ Bio for uliledlimab. Founded in 2014 and headquartered in Rockville, Maryland, the entity was formerly named I-Mab, with its transition to NovaBridge Biosciences slated for October 2025.
Precio por acción
$1.79
Última sincronización: 2026-09-02
Capitalización bursátil
$205.75M
Cambio (1 día)
3.18%
Cambio (1 año)
-61.61%
País
US
Comercio NovaBridge Biosciences (NBP)

Categoría

Historial del precio de la acción de NovaBridge Biosciences (NBP)
Precio más alto de cierre: $1.76 el 2026-09-01

Precio más bajo de cierre: $13.69 el 2020-01-01
Historial del precio de la acción de NovaBridge Biosciences desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -24.42%
2025 320.81%
2024 -37.56%
2023 -57.87%
2022 -92.59%
2021 24.83%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.05 -8.95%
AU
$757.71 6.76%
CH